SCHEMBL27173183

SCHEMBL27173183

CN(C)c1ccc(-c2ccc(-c3nc4ccc(NC(=O)O)cc4s3)cc2)cn1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 8/20 0.55
SMN1; SMN2 Q16637 6/20 0.49
KDM4E B2RXH2 6/20 0.49
NPC1 O15118 6/20 0.49
MAPT P10636 6/20 0.49
RAB9A P51151 5/20 0.49
ALDH1A1 P00352 5/20 0.49
MEN1 O00255 3/20 0.49
KMT2A Q03164 3/20 0.49
SULT1A1 P50225 1/20 0.49
POLB P06746 1/20 0.49
PKM P14618 1/20 0.49
TP53 P04637 2/20 0.48
HPGD P15428 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
RXFP1 Q9HBX9 1/20 0.47
KCNK2 O95069 1/20 0.46
KCNK4 Q9NYG8 1/20 0.46
SNCA P37840 1/20 0.46
LMNA P02545 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30006266 1.00 APP (0.55) APPSMN1; SMN2KDM4ENPC1MAPT
SCHEMBL30828341 0.89 APP (0.53) APPSMN1; SMN2KDM4ENPC1MAPT
SCHEMBL23364361 0.86 APP (0.53) APPSMN1; SMN2KDM4ENPC1MAPT
SCHEMBL29874189 0.86 APP (0.53) APPSMN1; SMN2KDM4ENPC1MAPT
SCHEMBL27173193 0.86 APP (0.46) APPSMN1; SMN2KDM4ENPC1MAPT
SCHEMBL28786192 0.83 APP (0.52) APPSMN1; SMN2KDM4ENPC1MAPT
SCHEMBL26518067 0.83 APP (0.57) APPMAPTSNCA
SCHEMBL13394576 0.81 APP (0.62) APPMAPTMEN1KMT2ASULT1A1
SCHEMBL14450187 0.81 APP (0.67) APPMAPTMEN1KMT2ASULT1A1
SCHEMBL29453199 0.81 APP (0.76) APPSMN1; SMN2MAPTSULT1A1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4337259-A1 COMPOUNDS FOR DEGRADING ALPHA-SYNUCLEIN AGGREGATES AND USES THEREOF Aprinoia Therapeutics Limited (HK) 2024-03-20 EP disclosed
WO-2022238737-A1 COMPOUNDS FOR DEGRADING ALPHA-SYNUCLEIN AGGREGATES AND USES THEREOF APRINOIA THERAPEUTICS LIMITED (CN) 2022-11-17 WO disclosed